Real-life efficacy of biologicals in patients with severe asthma phenotype overlap. Experiences from a tertiary pulmonary centre

被引:0
|
作者
Sleiman, Y. [1 ]
Lacwik, P. [1 ,2 ]
Moscicka, A. [1 ]
Ochab-Krupnik, D. [1 ]
Palczynski, C. [2 ]
机构
[1] Holy Cross Ctr Lung Dis, Checiny, Poland
[2] Jan Kochanowski Univ, Kielce, Poland
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
100524
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany
    Korn, S.
    Thielen, A.
    Seyfried, S.
    Taube, C.
    Kornmann, O.
    Buhl, R.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1725 - 1731
  • [32] Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
    Vadasz, Zahava
    Tal, Yuval
    Rotem, Menachem
    Shichter-Confino, Vered
    Mahlab-Guri, Keren
    Graif, Yael
    Kessel, Aharon
    Agmon-Levin, Nancy
    Maoz-Segal, Ramit
    Kivity, Shmuel
    Benor, Shira
    Lachover-Roth, Idit
    Zeldin, Yuri
    Stein, Migel
    Toker, Ori
    Hassoun, Gamal
    Bezalel-Rosenberg, Shira
    Toubi, Elias
    Asher, Ilan
    Sthoeger, Zev
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1743 - 1745
  • [33] Real-Life Response to Biologics in Severe Asthma with Nasal Polyposis: Insights from the Belgian Severe Asthma Registry
    Demolder, Femke
    Vanderhelst, Eef
    Verbanck, Sylvia
    Schleich, Florence
    Louis, Renaud
    Brusselle, Guy
    Sohy, Carine
    Michils, Alain
    Peche, Rudi
    Pilette, Charles
    Hanon, Shane
    LUNG, 2024, 202 (04) : 441 - 448
  • [34] Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma
    Pereira Barbosa, M.
    Bugalho de Almeida, A.
    Pereira, C.
    Chen, C. -W.
    Georgiou, P.
    Peachey, G.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2015, 21 (03) : 151 - 156
  • [35] Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre
    Drabbe, C.
    Benson, C.
    Younger, E.
    Zaidi, S.
    Jones, R. L.
    Judson, I
    Chisholm, J.
    Mandeville, H.
    Fisher, C.
    Thway, K.
    Al Muderis, O.
    Messiou, C.
    Strauss, D.
    Husson, O.
    Miah, A.
    Van der Graaf, W. T. A.
    CLINICAL ONCOLOGY, 2020, 32 (01) : E27 - E35
  • [36] Real-life efficacy and safety of secukinumab: results from a tertiary hospital in Greece
    Tsentemeidou, A.
    Sotiriou, E.
    Vakirlis, E.
    Sideris, N.
    Papadimitriou, I.
    Lazaridou, E.
    Ioannides, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (02) : E50 - E51
  • [37] Real-life evaluation of the safety, efficacy and therapeutic outcomes of endoscopic submucosal dissection in a Western tertiary centre
    Santos-Antunes, Joao
    Baldaque-Silva, Francisco
    Marques, Margarida
    Lopes, Joanne
    Carneiro, Fatima
    Macedo, Guilherme
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (05) : 702 - 709
  • [38] A study into efficacy of omalizumab therapy in patients with severe persistent allergic asthma at a tertiary referral centre for asthma in Ireland
    Subramaniam, A.
    Al-Alawi, M.
    Hamad, S.
    O'Callaghan, J.
    Lane, S. J.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2013, 106 (07) : 631 - 634
  • [39] Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience
    Pose, Elisa
    Sola, Elsa
    Piano, Salvatore
    Gola, Elisabetta
    Graupera, Isabel
    Guevara, Monica
    Cardenas, Andres
    Angeli, Paolo
    Gines, Pere
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (03): : 372 - 375
  • [40] Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
    Kralimarkova, Tanya
    Staevska, Maria
    Lazarova, Tsvetelina
    Hristova, Diana
    Dimitrov, Vasil
    Popov, Todor
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46